CTM is one integrated AI-enabled enrollment engine that finds the right patients, converts more of them to randomization, and supports them to study completion. Our enrollment engine, built on over 30 years of enrollment expertise, brings together people, technology, and data intelligence to drive unsurpassed results across a broad range of therapeutic areas, from routine to rigorous phase 2 and phase 3 trials.
Analytics and automation deliver speed, precision and visibility while CTM experts bring the strategy, experience, empathy, and human connection needed to engage and guide patients.
StudyMax™ is our proprietary AI-enabled technology platform that powers the engine, connecting patients, sites, and sponsors through the enrollment journey. RandIQ™, our data intelligence layer, assimilates all of our learnings, over thousands of studies and millions of patients, to drive StudyMax solution development and continuous improvement in our approach to deliver consistently better predictive forecasts and ultimately, unparalleled results.
Patient Identification - find and reach patients most likely to qualify
Patient Engagement – nurse-led conversations lend empathy, provide education, and foster confidence and commitment
Screening – several layers of verification of potential eligibility before referral
Site Enablement - reduce site burden by referring pre-qualified patients, ready to enroll
Reporting & Optimization – track patients and performance real-time to continuously optimize recruitment and turn study data into intelligence that improves future forecasting and results
randomizations
randomizations
andomizations
randomizations